Atlas Trials

Seqirus

53 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Seqirus

RecordFirmDate
The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older (NCT06015282)Seqirus2023-11-03
A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age (NCT06087640)Seqirus2023-10-23
Safety, Reactogenicity, and Immunogenicity Study of a Self-Amplifying MRNA Influenza Vaccine in Healthy Adults (NCT06028347)Seqirus2023-10-05
Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults (NCT05875961)Seqirus2023-06-15
Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults (NCT05874713)Seqirus2023-06-07
Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age (NCT05501561)Seqirus2022-08-25
A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed (NCT05422326)Seqirus2022-07-18
A Clinical Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Quadrivalent Influenza Vaccine Compared With a Licensed Quadrivalent Vaccine in Adults 50 to 64 Years of Age (NCT05044195)Seqirus2021-09-30
Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults (NCT04782323)Seqirus2021-04-13
A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine (NCT04669691)Seqirus2020-12-19
An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older (NCT04806529)Seqirus2020-12-15
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults (NCT04576702)Seqirus2020-10-08
Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects (NCT04074928)Seqirus2019-09-06
Efficacy Study With QIVc in Pediatric Subjects (NCT03932682)Seqirus2019-05-13
Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults (NCT03314662)Seqirus2017-10-17
Afluria Pregnancy Registry (NCT03442582)Seqirus2017-09-08
Flucelvax (TIVc or QIVc) Pregnancy Registry (NCT03438487)Seqirus2017-09-01

Track Seqirus automatically

Every clearance here is in the API, with alerts when new ones post.